Please try another search
SynBiotic SE engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety. It also offers hemp, cannabinoids, dietary supplements, and cosmetic products; medical cannabis products; and cannabis products for recreational use under the Hempamed, Princess Stardust, The Hempany, and Hempamed Rx brand names. The company was formerly known as Ledgertech SE and changed its name to SynBiotic SE. SynBiotic SE was founded in 2015 and is based in Munich, Germany.
Name | Age | Since | Title |
---|---|---|---|
Sebastian Stietzel | - | - | Chairman of the Board of Directors |
Lars Muller | - | - | CEO & Director |
Thomas Hanke | - | 2020 | Director |
Marlon Braumann | - | 2020 | Deputy Chairman |
Bruce A. Linton | 56 | 2022 | Chairman of Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review